Sandbox/a: Difference between revisions
< Sandbox
m (Changes made per Mahshid's request) |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 6: | Line 6: | ||
==History and Symptoms== | ==History and Symptoms== | ||
{| style="float: right; border: 0px; font-size: 90%; margin: 3px;" | {|style="float: right; border: 0px; font-size: 90%; margin: 3px;" | ||
! style="width: | ! style="width: 150px; background: #4479BA"|{{fontcolor|#FFF| '''''Symptom '''''}} | ||
! style="width: | ! style="width: 100px; background: #4479BA"|{{fontcolor|#FFF| '''''Percentage '''''}} | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"| Fever <br> Fever with chills or rigors | ||
| style=" | | style="background: #F5F5F5"| 98% <br> 87% | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"| Cough <br> Dry <br> Productive | ||
| style=" | | style="background: #F5F5F5"|83% <br> 47% <br> 36% | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"|Hemoptysis | ||
| style=" | | style="background: #F5F5F5"|17% | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"|Shortnes of breath | ||
| style=" | | style="background: #F5F5F5"|72% | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"|Chest Pain | ||
| style=" | | style="background: #F5F5F5"|15% | ||
|- | |||
| style="background: #F5F5F5"|Sore throat | |||
| style="background: #F5F5F5"|21% | |||
|- | |||
| style="background: #F5F5F5"| Runny Nose | |||
| style="background: #F5F5F5"|4% | |||
|- | |||
| style="background: #F5F5F5"| Abdominal Pain | |||
| style="background: #F5F5F5"|17% | |||
|- | |||
| style="background: #F5F5F5"| Nausea | |||
| style="background: #F5F5F5"|21% | |||
|- | |||
| style="background: #F5F5F5"| Vomiting | |||
| style="background: #F5F5F5"|21% | |||
|- | |- | ||
| style=" | | style="background: #F5F5F5"| Diarrhoea | ||
| style=" | | style="background: #F5F5F5"|26% | ||
|- | |- | ||
| style=" | | style="background: #F5F5F5"| Myalgia | ||
| style=" | | style="background: #F5F5F5"|32% | ||
|- | |- | ||
| style="background: #F5F5F5"| Headache | |||
| style="background: #F5F5F5"|13% | |||
|} | |} | ||
| Line 54: | Line 68: | ||
** Vomiting (21%) | ** Vomiting (21%) | ||
All but two patients (96%) had one or more chronic medical conditions, including [[diabetes]] (68%), [[hypertension]] (34%), [[heart disease]] (28%), and [[kidney disease]] (49%). Thirty-four (72%) had more than one chronic condition. | All but two patients (96%) had one or more chronic medical conditions, including [[diabetes]] (68%), [[hypertension]] (34%), [[heart disease]] (28%), and [[kidney disease]] (49%). Thirty-four (72%) had more than one chronic condition. In a retrospective study on 47 patients with MERS-CoV infection, 42 (89%) needed intensive care and 34 (72%) had mechanical ventilation.<ref name="pmid23891402">{{cite journal| author=Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A et al.| title=Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. | journal=Lancet Infect Dis | year= 2013 | volume= 13 | issue= 9 | pages= 752-61 | pmid=23891402 | doi=10.1016/S1473-3099(13)70204-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23891402 }} </ref> | ||
==References== | ==References== | ||
| Line 62: | Line 76: | ||
{{WS}} | {{WS}} | ||
[[category:disease]] | [[category:disease]] | ||
[[category:virology]] | [[category:virology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
Latest revision as of 18:42, 18 September 2017
|
Middle East Respiratory Syndrome Coronavirus Infection Microchapters |
|
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sandbox/a On the Web |
|
American Roentgen Ray Society Images of Sandbox/a |
|
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The symptoms of the middle east respiratory syndrome coronavirus infection include fever, cough, shortness of breath and gatsrointestinal symptoms.
History and Symptoms
| Symptom | Percentage |
|---|---|
| Fever Fever with chills or rigors |
98% 87% |
| Cough Dry Productive |
83% 47% 36% |
| Hemoptysis | 17% |
| Shortnes of breath | 72% |
| Chest Pain | 15% |
| Sore throat | 21% |
| Runny Nose | 4% |
| Abdominal Pain | 17% |
| Nausea | 21% |
| Vomiting | 21% |
| Diarrhoea | 26% |
| Myalgia | 32% |
| Headache | 13% |
Suspect MERS-CoV infection in case of:
- Fever (≥38°C, 100.4°F) and pneumonia or acute respiratory distress syndrome (based on clinical or radiological evidence);
AND EITHER
- History of travel from countries in or near the Arabian Peninsula1 within 14 days before symptom onset;
OR
- Close contact2 with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula;
OR
- Is a member of a cluster of patients with severe acute respiratory illness (e.g. fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated, in consultation with state and local health departments.
Symptoms
- Fever (98%)
- Cough (83%)
- Shortness of breath (72%)
- Gastrointestinal symptoms
- Diarrhea (26%)
- Vomiting (21%)
All but two patients (96%) had one or more chronic medical conditions, including diabetes (68%), hypertension (34%), heart disease (28%), and kidney disease (49%). Thirty-four (72%) had more than one chronic condition. In a retrospective study on 47 patients with MERS-CoV infection, 42 (89%) needed intensive care and 34 (72%) had mechanical ventilation.[1]
References
- ↑ Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A; et al. (2013). "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study". Lancet Infect Dis. 13 (9): 752–61. doi:10.1016/S1473-3099(13)70204-4. PMID 23891402.